Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1,2 Diketone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solvent-free synthesis of anticancer intermediate CN102911177A. High yield, green chemistry, scalable for API manufacturing.
Patent CN102070383A details a green Ru-catalyzed oxidation of olefins to 1,2-diketones. Offers high selectivity, broad substrate scope, and cost-effective manufacturing for pharma intermediates.
Novel oxidation method for 1,2-diketones using iodobenzene diacetate. Offers mild conditions and high purity for pharmaceutical intermediates.
Patent CN113264816B reveals a catalyst-free sulfur ylide route for spiro[cyclopropane-1,2'-indene]-1',3'-diketones. Achieve high diastereoselectivity and cost efficiency.
Patent CN104892377B reveals zinc-catalyzed alkyne oxidation for high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability for global buyers.
Patent CN110028407B details a novel rare earth catalyzed one-pot synthesis for spiro cyclopropane indene diketones, offering high stereoselectivity and cost-effective manufacturing for global supply chains.
Patent CN109776529B reveals a green, catalyst-free route for 1,2-diketone imidazoles, offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN113264816A reveals a base-catalyzed route for high-purity spiro cyclopropane derivatives, offering significant cost reduction in API manufacturing and scalable production.